(AZ) is one of the leading research-driven biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialization of primary care and specialty care medicines that transform lives. AZ employs around 70,000 people worldwide and operates in more than 100 countries. The Gothenburg R&D site is one of the major AZ research centers. The Molecular AI team in Discovery Sciences focuses on ML/AI applications in drug design. The team drives the science, build platforms and impact projects through applying ML/AI to drug design. It has state-of-the-art computational tools and high performance computing resources. The team works in an interdisciplinary environment by closely interacting with experts from chemistry automation and medicinal chemistry, and have extensive experience working in EU and Swedish government funded projects, such as WASP, IMI2-MELLODDY, H2020-ExCAPE, H2020-BIGCHEM, etc.